LimFlow Raises €27 Million ($33.5 Million) in Series C Financing Led by Sofinnova Partners to Advance Innovative Critical Limb Ischemia (CLI) Treatment

Download

• Small JPEG, 344x106, 27.7 KB
• Preview JPEG, 144x44, 16.5 KB
• Thumbnail JPEG, 120x37, 15.3 KB